The effect of octreotide on breathing and the ventilatory response to CO2 in conscious dogs

European Respiratory Journal

Volumn 11, Issue 6, 1998, Pages 1376-1381

  Cao, K ^a,b   Grunstein, R R ^a,b   Ho, K Y ^c   Sullivan, C E ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Breathing control; Central chemical receptor; Octreotide; Respiration; Somatostatin analogue; Ventilatory response to CO2

Indexed keywords

CARBON DIOXIDE; OCTREOTIDE; PLACEBO; SODIUM CHLORIDE; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BREATHING PATTERN; BREATHING RATE; CARBON DIOXIDE BREATHING; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LUNG MINUTE VOLUME; LUNG VENTILATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATION CONTROL; TIDAL VOLUME;

ANIMALS; CARBON DIOXIDE; DOGS; HORMONES; HYPERCAPNIA; OCTREOTIDE; PULMONARY VENTILATION; RESPIRATION; SODIUM CHLORIDE; TIDAL VOLUME;

EID: 0031862164     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11061376     Document Type: Article

References (28)

1. Reichlin S. Somatostatin. [review]. N Engl J Med 1983; 309: 1495-1501.
2. Frohman LA, Downs TR, Clarke IJ. Measurement of growth hormone releasing hormone and somatostatin in hypothalamic portal plasma of unanaesthetised sheep. Spontaneous secretion and response to insulin-hypoglycemia. J Clin Invest 1990; 86: 17-24.
3. Iranmanesh A, Veldhuis JD. Clinical pathophysiology of the somatotropic (GH) axis in adults. Endocrinol Metab Clin N Am 1992; 21: 783-816.
4. Melmed S. Acromegaly. N Engl J Med 1990; 322: 966-977.
5. Kalia M, Fuxe K, Agnati LF, Hokfelt T, Harfstrand A. Somatostatin produces apnea and is localised in medullary respiratory nuclei: a possible role in apneic syndromes. Brain Res 1984; 296: 339-344.
6. Harfstrand A, Kalia M, Fuxe K, Kaijser L, Agnati LR. Somatostatin induced apnoea: interaction with hypoxia and hypercapnia in the rat. Neurosci Lett 1984; 50: 37-42.
7. Harfstrand A, Fuxe K, Kalia M, Agnati LF. Somatostatin induced apnoea: prevention by central and peripheral administration of the opiate receptor blocking agent naloxone. Acta Physiol Scand 1985; 125: 91-95.
8. Millhorn DE, Hokfelt T, Terenius L, Buchan A, Brown JC. Somatostatin- and enkephalin-like immunoreactivities are frequently colocalized in neurons in the caudal brain stem of rat. Exp Brain Res 1987; 67: 420-428.
9. Chen Z, Hedner T, Hedner J. Local application of somatostatin in the rat ventrolateral brain medulla induces apnea. J Appl Physiol 1990; 69: 2233-2238.
10. Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analog of somatostatin with prolonged action. Life Sci 1982; 31: 1133-1140.
11. Lamberts SW, Reubi JC, Krenning EP. Somatostatin analogues in the treatment of acromegaly. Endocrinol Metabol Clin N Am 1992; 21: 737-752.
12. Ho KY, Weissberger AJ, Marbach P, Lazarus L. Therapeutic efficacy of the somatostatin analog SMS 201-995 (Octreotide) in acromegaly. Effects of dose and frequency and long term safety. Ann Intern Med 1990; 112: 173-181.
13. Reichlin S. Somatostatin. Basic and Clinical Status. Plenum Press, New York, 1987.
14. Maxwell DL, Chahal P, Nolop KB, Hughes JM. Somatostatin inhibits the ventilatory response to hypoxia in humans. J Appl Physiol 1986; 60: 997-1002.
15. Kobayashi S, Nishimura M, Taguchi H, Miyamoto K, Kawakami Y. Effect of octreotide on ventilation and dyspnea sensation in a patient with cirrhotic hypoxemia. Intern Med 1995; 34(5): 401-405.
16. Filuk RB, Berezanski DJ, Anthonisen NR. Depression of hypoxic ventilatory response in humans by somatostatin. J Appl Physiol 1988; 65: 1050-1054.
17. Grunstein RR, Ho KY, Berthon-Jones M, Stewart D, Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994; 150: 496-502.
18. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991; 115: 527-532.
19. Grunstein RR, Ho KY, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in acromegaly. Ann Intern Med 1994; 121: 478-483.
20. Read DJ. A clinical method for assessing the ventilatory response to carbon dioxide. Aust Ann Med 1967; 16: 20-32.
21. Fuxe K, Agnati LF, Harftrand A, et al. Cardiovascular and respiratory actions of somatostatin peptides following intracisternal injection into the alpha-chloralose anaesthetised rat. Neurosci Lett Suppl 1982; 10: 189.
22. Yamamoto Y, Runold M, Prabhakar N, Pantaleo T, Lagercrantz H. Somatostatin in the control of respiration. Acta Physiol Scand 1988; 134: 529-533.
23. Chen Z. Substance P and somatostatin-potent modulators of respiratory regulation in the rat medulla oblongata. PhD thesis, University of Goteborg, Sweden, 1993.
24. Danguir J, De Saint-Hilaire Kafi S. Reversal of desipramine-induced suppression of paradoxical sleep by a long acting somatostatin analogue (octreotide) in rats. Neurosci Lett 1989; 98: 154-158.
25. Epelbaum J, Dournaud P, Fodor M, Viollet C. The neurobiology of somatostatin. Crit Rev Neurobiol 1994; 8(1-2): 25-44.
26. Scott SC, Inman JD, Moss IR. Modulation by mu opioid antagonism of sleep and respiration in neonatal swine. Respir Physiol 1991; 85: 257-269.
27. Jones RL, Neary JM, Ryan TG. Normal values for the hypercapnic ventilation response; effects of age and the ability to ventilate. Respiration 1993; 60: 197-202.
28. Saunders NA, Leeder SR, Rebuck AS. Ventilatory response to carbon dioxide in young athletes: a family study. Am Rev Respir Dis 1976; 113: 497-502.